How does the brain know whether our actions actually make a difference?

by Champalimaud Centre for the UnknownIn "controllable houses", the door's color determines which room it leads to. In contrast, in "uncontrollable houses" the sequence of room

Updated on: February 21,2024

How does the brain know whether our actions actually make a difference?

by Champalimaud Centre for the UnknownIn "controllable houses", the door's color determines which room it leads to. In contrast, in "uncontrollable houses" the sequence of room

Updated on:February 21,2024

Excessive daytime sleepiness linked with brain protein involved in Alzheimer's disease

by Johns Hopkins University Bloomberg School of Public HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainAnalysis of data captured during a long-term study of agi

Updated on: April 25,2024

Excessive daytime sleepiness linked with brain protein involved in Alzheimer's disease

by Johns Hopkins University Bloomberg School of Public HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainAnalysis of data captured during a long-term study of agi

Updated on:April 25,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on: April 16,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on:April 16,2024

COVID-19: Advice for caring for people with Alzheimer's disease, mild cognitive impairment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWith the COVID-19 pandemic at the forefront of daily life, how much information should you share with a loved one who has Alzheimer's disea

Updated on: March 26,2024

COVID-19: Advice for caring for people with Alzheimer's disease, mild cognitive impairment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWith the COVID-19 pandemic at the forefront of daily life, how much information should you share with a loved one who has Alzheimer's disea

Updated on:March 26,2024

New study shows promising diagnosis of multiple sclerosis from images of the eye

byDurham UniversitySaliency maps generated for eight SLO images and OCT thickness maps of the total retina of (A) HC and (B) MS subjects from the test dataset when the best-performing model trai

Updated on: July 31,2024

New study shows promising diagnosis of multiple sclerosis from images of the eye

byDurham UniversitySaliency maps generated for eight SLO images and OCT thickness maps of the total retina of (A) HC and (B) MS subjects from the test dataset when the best-performing model trai

Updated on:July 31,2024

Structural analysis of relevant drug targets for Alzheimer's disease

by Bentham Science PublishersAlzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant

Updated on: March 07,2024

Structural analysis of relevant drug targets for Alzheimer's disease

by Bentham Science PublishersAlzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant

Updated on:March 07,2024

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on: March 02,2024

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on:March 02,2024

Forty percent of dementia cases could be prevented or delayed by targeting 12 risk factors throughout life

by LancetCredit: CC0 Public DomainModifying 12 risk factors over the lifecourse could delay or prevent 40% of dementia cases, according to an update toThe LancetCommission on dementia

Updated on: March 13,2024

Forty percent of dementia cases could be prevented or delayed by targeting 12 risk factors throughout life

by LancetCredit: CC0 Public DomainModifying 12 risk factors over the lifecourse could delay or prevent 40% of dementia cases, according to an update toThe LancetCommission on dementia

Updated on:March 13,2024

Brain stimulation shows promise for Alzheimer's disease in early trial

by Alzheimer's Research UKPET scan of a human brain with Alzheimer's disease. Credit: public domainScientists in the US have found that electrically stimulating regions of the brain in th

Updated on: May 13,2024

Brain stimulation shows promise for Alzheimer's disease in early trial

by Alzheimer's Research UKPET scan of a human brain with Alzheimer's disease. Credit: public domainScientists in the US have found that electrically stimulating regions of the brain in th

Updated on:May 13,2024

Study reveals how obesity could accelerate aging in the brain

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainA new study conducted in mice traces how obesity and a high-fat diet may accelerate aging in the blood vessels that supply blood

Updated on: April 28,2024

Study reveals how obesity could accelerate aging in the brain

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainA new study conducted in mice traces how obesity and a high-fat diet may accelerate aging in the blood vessels that supply blood

Updated on:April 28,2024

AAIC: Turnover kinetics vary for different amyloid beta isoforms

(HealthDay)—Amyloid beta (Aβ)38 has faster turnover kinetics than Aβ40 and Aβ42, according to a study published online July 19 inAlzheimer's & Dementiato coincide with presentation

Updated on: March 19,2024

AAIC: Turnover kinetics vary for different amyloid beta isoforms

(HealthDay)—Amyloid beta (Aβ)38 has faster turnover kinetics than Aβ40 and Aβ42, according to a study published online July 19 inAlzheimer's & Dementiato coincide with presentation

Updated on:March 19,2024

Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer's

by University of SussexCredit: Fakurian DesignIn a world first, scientists from the University of Sussex have recorded blood oxygen levels in the hippocampus and provided experimental proof for w

Updated on: March 09,2024

Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer's

by University of SussexCredit: Fakurian DesignIn a world first, scientists from the University of Sussex have recorded blood oxygen levels in the hippocampus and provided experimental proof for w

Updated on:March 09,2024